Cite
Taieb V, Pacou M, Van Sanden S, et al. Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv). Value Health. 2014;17(7):A665doi: 10.1016/j.jval.2014.08.2450.
Taieb, V., Pacou, M., Van Sanden, S., Sbarigia, U., Mehnert, A., & Duchesne, I. (2014). Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv). Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A665. https://doi.org/10.1016/j.jval.2014.08.2450
Taieb, V, et al. "Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv)." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A665. doi: https://doi.org/10.1016/j.jval.2014.08.2450
Taieb V, Pacou M, Van Sanden S, Sbarigia U, Mehnert A, Duchesne I. Mixed Treatment Comparisons to Compare Simeprevir with Boceprevir and Telaprevir in Combination with Peg-Interferon Alpha and Ribavirin (Pr) in Patients Infected with Genotype 1 Hepatitis C Virus (Hcv). Value Health. 2014 Nov;17(7):A665. doi: 10.1016/j.jval.2014.08.2450. Epub 2014 Oct 26. PMID: 27202427.
Copy
Download .nbib
